In a male patient with hyperprolactinemia, elevated total testosterone, elevated sex hormone‑binding globulin, and elevated bioavailable testosterone, what is the most likely diagnosis?

Diagnostic Assessment

Your laboratory findings most likely indicate a prolactin-secreting pituitary microadenoma (prolactinoma), though medication-induced hyperprolactinemia and other secondary causes must be excluded first.

Understanding Your Results

Your prolactin level of 46.4 ng/mL (approximately 982 mIU/L) is elevated approximately 3-fold above the upper limit of normal. According to Endocrine Society guidelines, prolactin levels between 25-100 ng/mL can be caused by either prolactinomas or secondary causes 11. The paradoxical elevation in your testosterone and SHBG levels, rather than the expected suppression, is the key to narrowing the differential diagnosis.

Primary Differential Diagnoses

1. Medication-Induced Hyperprolactinemia (MUST EXCLUDE FIRST)

• Certain medications cause hyperprolactinemia at levels similar to yours (25-100 ng/mL range) 11
• Critical medications to review:
  • Antipsychotics (risperidone, olanzapine, phenothiazines) - can cause prolactin >200 ng/mL
  • Metoclopramide - can cause prolactin >200 ng/mL
  • Verapamil - causes hyperprolactinemia in 8.5% of patients
  • Opiates and cocaine
• If you are taking ANY of these medications, this is the most likely diagnosis 11

2. Prolactin-Secreting Microadenoma (Most Likely if Not Medication-Induced)

• Your prolactin level of 46.4 ng/mL falls within the typical range for microadenomas (mean 99 ng/mL, range 16-385 ng/mL in men) 11
• Prolactinomas typically cause LOW testosterone, not high - your elevated testosterone is atypical 11
• The prevalence in men undergoing evaluation is approximately 20 per 100,000 1

3. Exogenous Testosterone Use with Secondary Hyperprolactinemia

• This could explain your paradoxically HIGH testosterone levels
• Testosterone replacement can induce hyperprolactinemia through aromatization to estradiol, which stimulates prolactin release 2
• Your elevated SHBG (105 nmol/L) and high bioavailable testosterone (199.99 ng/dL) are consistent with supraphysiologic androgen exposure
• Critical question: Are you taking testosterone, prohormones, or anabolic steroids?

4. Other Secondary Causes to Exclude

• Hypothyroidism - check TSH
• Chronic renal failure - check creatinine
• Cirrhosis - check liver function
• Chest wall lesions
• Pituitary stalk compression from non-functioning adenoma 34

Recommended Diagnostic Workup

Step 1: Medication and Supplement Review

• Immediately review ALL medications, supplements, and performance-enhancing substances
• If taking dopamine antagonists, this is your diagnosis 11
• If taking testosterone/androgens, this likely explains both findings 2

Step 2: Repeat Prolactin Measurement

• Single measurement without venipuncture stress is sufficient for diagnosis 11
• However, given the atypical presentation with high testosterone, confirm the prolactin elevation

Step 3: Additional Hormonal Testing

• TSH and free T4 (exclude hypothyroidism)
• Estradiol level (if testosterone use suspected - will be elevated) 2
• LH and FSH (typically suppressed in prolactinomas, may be altered with exogenous testosterone)
• Morning cortisol and IGF-1 (assess other pituitary function)

Step 4: Pituitary MRI

• Obtain MRI if prolactin remains elevated after excluding medications/supplements 11
• Microadenomas (<10mm) are most common with your prolactin level
• MRI should be performed even with modest prolactin elevation to exclude stalk compression

Clinical Implications

If Prolactinoma is Confirmed:

Your atypically HIGH testosterone is unusual and requires explanation:

• Most men with prolactinomas present with LOW testosterone and hypogonadism 56
• Your elevated SHBG (105 nmol/L) and high bioavailable testosterone suggest either:
  • Concurrent exogenous androgen use
  • Unusual metabolic state (diabetes can elevate SHBG and testosterone) 7
  • Laboratory artifact requiring confirmation

Treatment Considerations (If Prolactinoma Confirmed):

Cabergoline is the preferred dopamine agonist with 80% normalization rate in men with micro/macroadenomas 111:

• Dose: 0.5-1 mg twice weekly
• Higher efficacy than bromocriptine
• Better tolerability and compliance
• Restores gonadal function in most cases within 6 months

However, treatment may not be immediately necessary if:

• You are asymptomatic (no sexual dysfunction, no galactorrhea)
• Microadenoma confirmed on MRI
• The Endocrine Society suggests NOT treating asymptomatic microprolactinomas 1

Critical Pitfalls to Avoid

1. Do not assume prolactinoma without excluding medications first - this is the most common reversible cause 11
2. Do not ignore the paradoxically elevated testosterone - this is NOT typical for prolactinoma and suggests either exogenous androgen use or concurrent metabolic condition 27
3. Do not start dopamine agonist therapy before obtaining MRI - need to exclude stalk compression from other lesions 1
4. If using testosterone replacement, be aware dopamine agonists do NOT suppress testosterone-induced hyperprolactinemia 2

Most Likely Clinical Scenario

Given your specific constellation of findings (elevated prolactin WITH elevated testosterone and SHBG rather than the expected suppression), the two most probable diagnoses are:

1. Exogenous testosterone/androgen use causing secondary hyperprolactinemia (if supplements/medications involved)
2. Incidental microprolactinoma in a patient with separate cause of elevated testosterone/SHBG (such as insulin-dependent diabetes, obesity, or metabolic syndrome) 7

Your immediate next step should be complete medication/supplement disclosure to your physician, followed by pituitary MRI if no causative agents are identified 11.